Skip to main content

Data Source

2017 National Survey on Drug Use and Health (NSDUH) Releases

These reports and detailed tables present estimates from the 2017 National Survey on Drug Use and Health (NSDUH).

View the recorded presentation of the NSDUH data and webcast slides presented by Dr. Elinore F. McCance-Katz.

Annual National Report

Key Substance Use and Mental Health Indicators in the United States

The 2017 Key Substance Use and Mental Health Indicators report summarizes the following:

  • Substance use (alcohol, tobacco, marijuana, cocaine, heroin, hallucinogens, and inhalants, as well as the misuse of opioids, prescription pain relievers, tranquilizers, stimulants, and sedatives)
  • Initiation of substance use
  • Perceived risk from substance use
  • Substance use disorders
  • Any mental illness, serious mental illness, and major depressive episode
  • Suicidal thoughts, plans, and non-fatal attempts for adults ages 18 or older
  • Substance use treatment and mental health service use

View the slides based on the Annual National Report: Key Substance Use and Mental Health Indicators in the United States (PPTX | 9.6 MB).

Detailed Tables

The 2017 NSDUH Detailed Tables present national estimates of substance use and mental health. The focus is on trends between 2016 and 2017 and from 2002 to 2017, as well as differences across population subgroups in 2017. Please refer to Section C of the Methodological Summary and Definitions report for more information.

Sections of the 2017 Detailed Tables:

For a description of changes to the measures and more about the organization and purposes of the tables and table indicators, please see the Introduction section of the tables.


The 2017 Methodological Summary and Definitions report summarizes the 2017 NSDUH methods and other supporting information that are relevant to estimates of substance use and mental health issues. This report is organized into seven sections:

  • Section A describes the survey, including information about the sample design; data collection procedures; and key aspects of data processing, such as development of analysis weights.
  • Section B presents technical details on the statistical methods and measurement, such as suppression criteria for unreliable estimates, statistical testing procedures, and issues for selected substance use and mental health measures.
  • Section C covers special topics for the redesigned NSDUH prescription drug questions, including the effects of 2017 questionnaire changes on estimates.
  • Section D includes a glossary that covers key definitions used in the NSDUH reports and detailed tables.
  • Section E describes other sources of data on substance use and mental health issues, including data sources for populations outside the NSDUH target population.
  • Section F lists references cited in the report.
  • Section G lists contributors to the report.